Article
Implication of UGT2B15 Genotype Polymorphism on Postoperative Anxiety Levels in Patients Receiving Lorazepam Premedication.
Anesthesia and analgesia - 1 Nov 2016
Mijderwijk Herjan, Klimek Markus, van Beek Stefan, van Schaik Ron H N, Duivenvoorden Hugo J, Stolker Robert Jan
Abstract excerpt
BACKGROUND: Lorazepam is used as premedication for its anxiolytic properties. The UGT2B15 genotype is of importance for the metabolism of lorazepam. The clinical effect of genetic polymorphisms in UGT2B15 genotype on the treatment of anxiety levels in same-day surgery patients receiving lorazepam, however, is unknown. METHODS: Three hundred ninety-eight same-day surgery patients of mixed sex (from a previous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
